has published results from a subgroup analysis of the Phase 3 study 309 comparing eribulin mesylate (marketed as Halaven Injection) with dacarbazine
in the Journal of Clinical Oncology, the company said.
In our study, Cisplatin, Etoposide, Bleomycin, Cyclophosphamide, Doxorubicin, Vincristine, 5-Flourouracil, Epirubicin, Paclitaxel, Vinblastine, Dacarbazine
, Carboplatin, Ifosfamide, Docetaxel, Oxaliplatin, were responsible for alopecia, as also in previous studies.
2) Historically, alkylating chemotherapy agents such as dacarbazine
and temozolomide have been used with limited efficacy.
The NEMO trial (NCT01763164) is the company's international, randomized Phase 3 study evaluating the safety and efficacy of 45 mg BID binimetinib, compared to 1,000 mg/m2 dacarbazine
dosed every three weeks.
Study 309 was a Phase III clinical study which examined the efficacy and safety of eribulin versus dacarbazine
in 452 patients aged 18 years and older with locally advanced, recurrent or metastatic soft tissue sarcoma (liposarcoma or leiomyosarcoma) who had disease progression following standard therapies (including an anthracycline and at least one other additional regimen).
The present study was designed to investigate the anticancer potential of saponin extracted from sea cucumber Holothuria teucospiiata alone and in combination with dacarbazine
on B16F10 melanoma cell line.
Therefore, the present study aims to find out histological changes induced by the treatment of one of the drugs used in cancer chemotherapy, Dacarbazine
, on testicular tissue and the effectiveness of propolis in the reduction of these changes.
Gone are the days where our active agents were interferon and dacarbazine
," said Dr.
The editor has organized the contributions that make up the main body of the text in three alphabetical volumes devoted to abarelix, barium enema, cancer biology, dacarbazine
, endocrine system tumors, xerostomia, zolpidem, and a wide variety of other related subjects in between.
, commonly used to treat skin cancer, was blended into the solution prior to crosslinking (a final part of the 3D printing process).
Bristol Myers Squibb, a global biopharmaceutical company, has reported positive results from a Phase III trial (CheckMate -066) comparing an investigational PD-1 immune checkpoint inhibitor, Opdivo, to the chemotherapy, dacarbazine
, in patients with treatment naive BRAF wild-type advanced melanoma, it was reported yesterday.
He received six cycles of chemotherapy containing bleomycin vinblastine doxorubicin and dacarbazine
which ended 2 months ago.